Shape Dependent Therapeutic Potential of Nanoparticulate System: Advance Approach for Drug Delivery
- PMID: 39034725
- DOI: 10.2174/0113816128314618240628110218
Shape Dependent Therapeutic Potential of Nanoparticulate System: Advance Approach for Drug Delivery
Abstract
Drug delivery systems rely heavily on nanoparticles because they provide a targeted and monitored release of pharmaceuticals that maximize therapeutic efficacy and minimize side effects. To maximize drug internalization, this review focuses on comprehending the interactions between biological systems and nanoparticles. The way that nanoparticles behave during cellular uptake, distribution, and retention in the body is determined by their shape. Different forms, such as mesoporous silica nanoparticles, micelles, and nanorods, each have special properties that influence how well drugs are delivered to cells and internalized. To achieve the desired particle morphology, shape-controlled nanoparticle synthesis strategies take into account variables like pH, temperatures, and reaction time. Top-down techniques entail dissolving bulk materials to produce nanoparticles, whereas bottom-up techniques enable nanostructures to self-assemble. Comprehending the interactions at the bio-nano interface is essential to surmounting biological barriers and enhancing the therapeutic efficacy of nanotechnology in drug delivery systems. In general, drug internalization and distribution are greatly influenced by the shape of nanoparticles, which presents an opportunity for tailored and efficient treatment plans in a range of medical applications.
Keywords: Cell uptake; bottom-up approach; cytotoxicity; internalization; therapeutic potential.; top-down approach.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.J Pharm Sci. 2013 Nov;102(11):3867-82. doi: 10.1002/jps.23691. Epub 2013 Aug 23. J Pharm Sci. 2013. PMID: 24037829
-
Strategies in the design of nanoparticles for therapeutic applications.Nat Rev Drug Discov. 2010 Aug;9(8):615-27. doi: 10.1038/nrd2591. Epub 2010 Jul 9. Nat Rev Drug Discov. 2010. PMID: 20616808 Review.
-
Applications of mesoporous materials as excipients for innovative drug delivery and formulation.Curr Pharm Des. 2013;19(35):6270-89. doi: 10.2174/1381612811319350005. Curr Pharm Des. 2013. PMID: 23470004 Review.
-
Recent update of toxicity aspects of nanoparticulate systems for drug delivery.Eur J Pharm Biopharm. 2021 Apr;161:100-119. doi: 10.1016/j.ejpb.2021.02.010. Epub 2021 Feb 25. Eur J Pharm Biopharm. 2021. PMID: 33639254 Review.
-
Nanosize drug delivery system.Curr Pharm Biotechnol. 2013;14(15):1221. doi: 10.2174/138920101415140804121008. Curr Pharm Biotechnol. 2013. PMID: 25106648
References
-
- Zhnag S.; Langer R.; Enteric elastomer enables safe gastric retention and extended oral drug delivery for improved medication adherence. Nanomedicine 2018,14(5),1841 - DOI
-
- Walia S; Acharya A.; Theragnosis: Nanoparticles as a tool for simultaneous therapy and diagnosis. Nanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue Regeneration 2016 - DOI
-
- Chia C.H.; Lau K.S.; Chin S.X.; Rosli N.H.; Vincent J.; Chowdhury M.S.; Carbon Nanotubes for Biomedical Applications and Health Care: New Horizons In Carbon Nanotubes for Biomedical Applications and Healthcare 2024,255-331 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources